By Mark Vermette, Principal Consultant, Halloran
Blog
Can the collaborative economy work in health care?
Airbnb and Uber have disrupted the hotel and taxi industries by finding and tapping unused assets. What’s in store for medicine?
By David Altman
Veniti raises $17m for Vici venous stent
Veniti said it nailed down a $17 million Series C financing it plans to use to advance testing and commercialization of its Vici venous stent system. The St. Louis-based medical device company said the round involved both debt and equity funding. Previous investors Baird Capital, Tekla Healthcare and Tekla Life Science Investors led the equity […]
Web offerings talk up the promise of genetic testing, but skip the limitations
By Tom Ulrich
The changing nature of what it means to be ‘diagnosed’
Meet the researcher behind “heart on a chip”
Cloudy with a diminishing chance of hype
By Mark Vermette, Principal Consultant, Halloran
FDA removes unregistered medical device establishments from database
By David Lennarz, Vice President and Co-Founder of Registrar Corp
Epilepsy surgery: When it’s not good to wait
About a third of children with epilepsy do not get better with drug treatment. Many physicians are inclined to try additional drugs to control the seizures – and there are many to choose from. However, analysis of data from tens of thousands of patients suggests that if two or more well-chosen drugs have failed, and surgery is a safe option, there’s no benefit in holding off.
Bacterial infections associated with duodenoscopes: FDA’s actions to understand the problem and what can be done to mitigate it
By William Maisel, M.D., M.P.H.
What’s your innovation style? Lion or ant?
By Vector Staff
From a series on researchers and innovators at Boston Children’s Hospital.
Kaifeng Liu, MD, a research fellow at Boston Children’s Hospital, takes his inspiration from ants.